XZXiangan Zhang

Xiangan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiangan Zhang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Linhan Zhang

    Proctology Department, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China

    2 shared publications
  • Menghua Shi

    Proctology Department, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China

    2 shared publications
  • Shuangxi Zhang

    Proctology Department, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China

    2 shared publications
  • Yongkang An

    Proctology Department, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China

    2 shared publications
  • Fang Wu

    1 shared publication
  • Fang Wufang

    Acupuncture Department, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China

    1 shared publication

Latest Publications

  • Open Access

    Procedure-Matched Comparison of TNBS/Ethanol Enema and DSS Free-Drinking Models of Ulcerative Colitis in Rats: Immune Endotype Profiling and a Translational Model-Selection Framework

    by Yongkang An, Fang Wufang, Linhan Zhang, Menghua Shi, Shuangxi Zhang, Xiang’AN Zhang

    Objective: Choosing between TNBS/ethanol enema and DSS free-drinking water protocols for establishing rat ulcerative colitis(UC) models remains a practical challenge in preclinical research. Beyond confirming that both methods induce colitis, no prior study has quantified the independent contribution of enema procedural trauma to inflammatory readouts, reported sex-stratified cytokine responses, or formally linked model-specific immune profiles to human UC endotypes. Methods: Ten SPF-grade SD rats(half male and half female) were allocated to a normal control, a procedure-matched saline enema control(anesthesia and enema without chemical agent), a TNBS group(100 mg/kg TNBS + 50% ethanol enema), and a DSS group(3% DSS free-drinking, 7 days). Endpoint assessments included body weight, colon length, macroscopic and histological scoring(modified Macpherson criteria, 0–10), and serum TNF-α and IL-6 by ELISA. Post-hoc exploratory analyses included sex-stratified cytokine sub-analysis and coefficient of variation(CV%) for each readout. Results: Both model groups successfully induced UC( P< 0.05 vs. controls for all endpoints). Critically, the procedure-matched saline enema control confirmed that colonic inflammation in the TNBS group was attributable to the chemical agent rather than mechanical trauma. TNBS induced significantly higher TNF-α(90.2±10.5 vs. 73.5±9.8 pg/mL, P< 0.05) and IL-6(66.5±8.3 vs. 53.2±7.6 pg/mL, P< 0.05) than DSS,consistent with Th1-polarized vs. innate barrier-disruption immune endotypes, respectively. Coefficient of variation analysis indicated greater intra-group variability in TNBS versus DSS, reflecting the procedural dependency of enema-based models. Conclusion: A procedure-matched control design is essential for valid TNBS-vs.-DSS comparisons and has been systematically underutilized in prior studies. Based on immune endotype alignment, TNBS is recommended for screening T-cell-targeted therapies and acute anti-inflammatory agents, while DSS is recommended for epithelial barrier repair and microbiome-modulating interventions. A model-selection decision framework derived from these data is provided to guide preclinical study design.

  • Open Access

    Schisandrin B Ameliorates Colonic Inflammation in Rats with Ulcerative Colitis by Regulating P62-mediated Autophagic Flux and the P65/caspase4 Signaling Axis

    by Yongkang An, Fang Wu, Menghua Shi, Huan Li, Linhan Zhang, Shuangxi Zhang, Xiang&Apos;An Zhang, Xiang-An Zhang

    Background: Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease with limited treatment options. Schisandrin B (Sch B), a bioactive lignan from Schisandra chinensis, has shown anti-inflammatory effects, but its regulatory mechanisms on autophagic flux and non-classical pyroptosis in UC remain unclear.Purpose: To investigate whether Sch B ameliorates colonic inflammation in UC rats by regulating P62-mediated autophagic flux and the P65/caspase4 signaling axis.Study design:In vivo animal study.Methods: A UC model was established in male SD rats using 2,4,6-trinitrobenzenesulfonic acid (TNBS). Rats were randomly divided into six groups(n=10 each): blank control, model, mesalazine (100 mg/kg), and Sch B low(10 mg/kg), medium(20 mg/kg), and high dose(50 mg/kg). Treatments were administered orally for 14 days. Disease activity index (DAI), colonic mucosal injury index(CMDI), and histopathological changes(HE staining) were assessed. Protein expression and localization of P62 and caspase4 were detected by immunohistochemistry (IHC). Western blotting was used to measure P62, phosphorylated P65(P-P65), total P65, and caspase4. Serum levels of IL-18, IL-17A, and IL-10 were measured by ELISA.Results: Compared with the blank group, the model group showed significantly increased DAI and CMDI scores, severe colonic mucosal damage, elevated P62 expression(P<0.01), increased P-P65/P65 ratio, upregulated caspase4 expression, higher serum IL-18 and IL-17A(P<0.01), and lower IL-10(P<0.01). Compared with the model group, Sch B(20 and 50 mg/kg) significantly ameliorated these changes in a dose-dependent manner(P<0.05 or P<0.01), with the high-dose group showing the most pronounced effects.Conclusion: Sch B effectively alleviates TNBS-induced colonic inflammation in UC rats by restoring P62-mediated autophagic flux, inhibiting P65 phosphorylation, downregulating caspase4-mediated non-classical pyroptosis, and rebalancing serum IL-18, IL-17A, and IL-10 levels.

  • Study on the effect and mechanism of Yanghe decoction Huacai ((sic) (sic) (sic)(sic)(sic)(sic)) ) on tissue repair of Yin syndrome after anal fistula surgery

    by Yijuan Wu, Xinghong Sun, Haixia Guo, Xiangan Zhang

    OBJECTIVE: To observe the clinical efficacy and safety of Yanghe decoction Huacai ((sic)(sic)(sic)(sic)(sic) ) for the repair of Yin syndrome wounds with slow-healing after anal fistula surgery. METHODS: A total of 120 patients with slow-healing negative wounds with after low-grade anal fistula surgery who met the inclusion criteria were divided into a treatment group and a control group based on a random number table method, with 60 patients in the treatment group and 60 patients in the control group. The treatment group was given Yanghe decoction Huacai in combination with routine treatment; the control group was only given routine treatment, in which the wound surface was disinfected with iodine, and then covered with sterile gauze. The course of treatment in both groups was 10 d. After treatment, the wound secretion score, wound granulation tissue score, the expression levels of basic fibroblast growth factor (bFGF), transforming growth factor (31 (TGF-(31), and epidermal growth factor (EGF) in the wound, wound healing time and clinical efficacy were compared. RESULTS: There was no significant difference in age or gender between the two groups (P P > 0.05). On the 10th and 15th days after the surgery, the wound secretion scores were higher in the treatment group than in the control group (P P < 0.01). Comparing the two groups at the 10th and 15th day after surgery, the granulation tissue growth scores in the treatment group were better than the in control group (P P < 0.01). On the 10th and 15th day after operation, the expression levels of bFGF, TGF-(31 and EGF factors in the treatment group were stronger than those in the control group. The healing time of the wounds in the treatment group was significantly shorter than in the control group (P P < 0.01). The clinical efficacy of the two groups after treatment was compared, and the overall efficacy of the treatment group was significantly higher than that of the control group (P P < 0.01). CONCLUSIONS: Yanghe decoction Huacai have significant efficacy in the treatment of slow-healing wounds with Yin syndrome after anal fistula surgery. It improves wound secretions, promotes the growth of wound granulation tissue, and shortens wound healing time. Its mechanism of action may be related to the control of wound inflammation. It is related to increasing the expression of bFGF, TGF-(31 and EGF in wound tissue, and promoting wound angiogenesis and fibroblast proliferation.